Example orders for mFOLFOX6-B in colon cancer

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:48, 20 September 2012 by PeterYang (talk | contribs) (categories)
Jump to navigation Jump to search

Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.


mFOLFOX 6 & Bevacizumab (Avastin)

Original references may be found at mFOLFOX 6 & Bevacizumab (Avastin)

Example regimen #1

  • Fluorouracil (5-FU) 400 mg/m2 IV bolus over 10-15 minutes on days 1 & 15 after oxaliplatin and leucovorin
  • Fluorouracil (5-FU) 1200 mg/m2/day (total dose 2400 mg/m2) IV continuous infusion over 46 hours on days 1-2, 15-16, given after 5-FU bolus
  • Folinic acid (Leucovorin) 400 mg/m2 IV over 2 hours on days 1 & 15, given after bevacizumab, concurrently with oxaliplatin
    • Mixed in 250 mL D5W.
  • Oxaliplatin (Eloxatin) 85 mg/m2 IV over 2 hours on days 1 & 15, given after bevacizumab, concurrently with leucovorin
    • Mixed in 500 mL D5W, and only infuse through D5W line.
  • Bevacizumab (Avastin) 5 mg/kg IV on days 1 & 15, given first
    • Only infuse through NS line. Infusion times for bevacizumab are 90 for cycle 1, 60 minutes for cycle 2, then 30 minutes for cycles 3 and later.

28-day cycles

Supportive medications:

  • Ondansetron (Zofran) 8 mg IV 30 minutes prior to oxaliplatin
  • Dexamethasone (Decadron) 10 mg IV 30 minutes prior to oxaliplatin
  • Lorazepam (Ativan) 0.5-1 mg PO prn nausea/anxiety, given 30 minutes prior to chemotherapy
  • Calcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start prior to oxaliplatin to decrease likelihood of neuropathy
  • Calcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start after oxaliplatin infusion is complete to decrease likelihood of neuropathy

Hydration:

  • 500 ml D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml D5W.
  • 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.

Monitoring:

  • Hold if ANC <1500 or platelets <75 and notify physician.
  • Check blood pressure during and after the first two doses of bevacizumab; for the third dose and later, check blood pressure before and after bevacizumab.
  • Check urine protein every month; notify physician for urine protein >100 mg/dL.

Comments:

  • My institution administers this regimen in 28-day cycles.